Judith Feinberg
Dados Biográficos
| ID | 137274 |
|---|---|
| NOME | Judith Feinberg |
| PRENOMES | Judith |
| SOBRENOME | Feinberg |
| ASSINATURA | FEINBERG J |
| AFILIAÇÕES | West Virginia University |
| ORCID | 0000-0003-4206-7214 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 25 |
| TOTAL DE CITAÇÕES | 2 |
| TOTAL COMO AUTOR | 25 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 1997 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 1 |
Correlates of Rural Naloxone Possession Among People Who Use Drugs
Patterns of Felt Stigma Among Rural-Dwelling People Who Use Drugs
BACKGROUND: Stigma is a barrier to help-seeking in rural-dwelling people who use drugs. However, little is known about whether stigma is experienced in patterned ways, and what characteristics are associated with these patterns. METHODS: = 3048). We used three-step latent class analysis to classify participants by patterns of felt substance use stigma, then used multinomial logistic regression to explore demographic, health, and substance-related…
Use of fentanyl test strips by people who inject drugs
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on Covid-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C
Greater SDoH difficulties and lower self-efficacy were associated with greater inability to practice COVID-19 personal protective behaviors. Interventions to meet SDoH-related challenges and increase self-efficacy could help encourage practice of personal protective behaviors and economically reduce disease burden during health crises
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities
HCV antibody positivity, indicating prior exposure, was highest among those who had recently injected opioids, alone or with stimulants. Additional nucleic acid testing is necessary to confirm active infection. More research is needed to determine the underlying causes of HCV antibody positivity by injection use
Prevalence and correlates of multiple injections per injection episode among people who inject drugs in rural U.S. communities
Barriers to accessing medications for opioid use disorder among rural individuals
Access barriers vary by MOUD type for rural individuals with OUD. Compared to sublingual buprenorphine, methadone access was hindered more by transportation difficulties, while injectable long-acting buprenorphine was hindered more by affordability and finding a doctor or program. These barriers highlight the need to de-regulate and expand locations for methadone access and prescribing, and to improve affordability and prescriber uptake of newer …
The Aids Drug Assistance Program Is a Model for Chronic Disease Treatment Support
Use of fentanyl test strips by people who inject drugs
Declines in FTS use are consistent with what syringe services programs have been signaling for years. Needs assessments to gauge interest in FTS before scaling up can help ensure funding better spent on naloxone and syringes is not allocated to idle FTS. Increased FTS among women and racial minorities presents opportunities for tailored interventions. Recognizing trauma associated with witnessing overdoses as a growing component of the opioid epi…
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs
The War on Drugs, Racialized Capitalism, and Health Care Utilization Among White People Who Use Drugs in 22 Rural Appalachian Counties
Objectives. To analyze War on Drugs encounters and their relationships to health care utilization among White people who use drugs (PWUD) in 22 Appalachian rural counties in Kentucky, West Virginia, Ohio, and North Carolina. Methods. We recruited White PWUD using chain referral sampling in 2018 to 2020. Surveys asked about criminal–legal encounters, unmet health care needs, and other covariates. We used generalized estimating equations to regress…
Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs
BACKGROUND: Restrictive Medicaid policies regarding hepatitis C virus (HCV) treatment may exacerbate rural health care disparities for people who use drugs (PWUD). We assessed associations between Medicaid restrictions and HCV treatment among rural PWUD. METHODS: We compiled state-specific Medicaid treatment policies across 8 US rural sites in 10 states and merged these with participant survey data. We hypothesized that local restrictions regardi…
High suicidality predicts overdose events among people with substance use disorder
Introduction Suicide is the tenth leading cause of death in the United States and continues to be a major public health concern. Suicide risk is highly prevalent among individuals with co-occurring substance use disorders (SUD) and mental health disorders, making them more prone to adverse substance use related outcomes including overdose. Identifying individuals with SUD who are suicidal, and therefore potentially most at risk of overdose, is an…
Factors Associated with Non-Evidence-Based Overdose Responses among People Who Use Prescription Opioids Non-Medically in Rural Appalachia
These findings underscore the need to expand access to OEND in rural communities and indicate OEND is acceptable to training-naïve individuals who use opioids in rural Appalachia. Given the "harm reduction deserts" in the region, approaches to expand OEND should be pursued
Escalating costs of self-injury mortality in the 21st century United States
The scale and surge in the economic costs of SIM to society are large. Federal and state prevention and intervention programs should be financed with a clear understanding of the total costs-fiscal, social, and personal-incurred by deaths due to self-injurious behaviors
Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the Covid-19 pandemic
This measurement framework is intended to increase the quality and timeliness of research on the impacts of COVID-19 in the context of the current pandemic and future crises. Next steps include a ranking process to narrow the drivers of change in health risks to a concise set of indicators that adequately represent framework components, can be written as measurable indicators, and are quantifiable using existing data sources, as well as a publicl…
Supportive environments during the substance use disorder epidemic in the rural United States
A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips
The impact of rural classification systems on a comparison of risky drug-related behaviors in Kentucky and Ohio counties
To analyze county-level differences in injection drug use (IDU) behaviors and overdoses in Kentucky and Ohio, and to assess the impact of using different models to classify counties as rural.Existing clinical data were pooled from three regional programs: 1) an opioid overdose prevention program (OOPP) within a residential addiction treatment program (n=163), 2) a regional evaluation of four OOPPs (n=655), and 3) a mobile syringe services program…
Spirituality and religion in patients with HIV/Aids
Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an Aids clinical trial
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
BACKGROUND: The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We compared treatment with the protease inhibitor indinavir in addition to zidovudine and lamivudine with treatment with the two nucleosides alone in HIV-infected adults previously treated with zidovudine. METHODS: A total of 1156 patients not previously treated with lamivudin…
The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in Aids
The War on Drugs, Racialized Capitalism, and Health Care Utilization Among White People Who Use Drugs in 22 Rural Appalachian Counties
Objectives. To analyze War on Drugs encounters and their relationships to health care utilization among White people who use drugs (PWUD) in 22 Appalachian rural counties in Kentucky, West Virginia, Ohio, and North Carolina. Methods. We recruited White PWUD using chain referral sampling in 2018 to 2020. Surveys asked about criminal–legal encounters, unmet health care needs, and other covariates. We used generalized estimating equations to regress…
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
BACKGROUND: The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We compared treatment with the protease inhibitor indinavir in addition to zidovudine and lamivudine with treatment with the two nucleosides alone in HIV-infected adults previously treated with zidovudine. METHODS: A total of 1156 patients not previously treated with lamivudin…
The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in Aids
Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an Aids clinical trial
Spirituality and religion in patients with HIV/Aids
The impact of rural classification systems on a comparison of risky drug-related behaviors in Kentucky and Ohio counties
To analyze county-level differences in injection drug use (IDU) behaviors and overdoses in Kentucky and Ohio, and to assess the impact of using different models to classify counties as rural.Existing clinical data were pooled from three regional programs: 1) an opioid overdose prevention program (OOPP) within a residential addiction treatment program (n=163), 2) a regional evaluation of four OOPPs (n=655), and 3) a mobile syringe services program…
A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the Covid-19 pandemic
This measurement framework is intended to increase the quality and timeliness of research on the impacts of COVID-19 in the context of the current pandemic and future crises. Next steps include a ranking process to narrow the drivers of change in health risks to a concise set of indicators that adequately represent framework components, can be written as measurable indicators, and are quantifiable using existing data sources, as well as a publicl…
Supportive environments during the substance use disorder epidemic in the rural United States
High suicidality predicts overdose events among people with substance use disorder
Introduction Suicide is the tenth leading cause of death in the United States and continues to be a major public health concern. Suicide risk is highly prevalent among individuals with co-occurring substance use disorders (SUD) and mental health disorders, making them more prone to adverse substance use related outcomes including overdose. Identifying individuals with SUD who are suicidal, and therefore potentially most at risk of overdose, is an…
Factors Associated with Non-Evidence-Based Overdose Responses among People Who Use Prescription Opioids Non-Medically in Rural Appalachia
These findings underscore the need to expand access to OEND in rural communities and indicate OEND is acceptable to training-naïve individuals who use opioids in rural Appalachia. Given the "harm reduction deserts" in the region, approaches to expand OEND should be pursued
Escalating costs of self-injury mortality in the 21st century United States
The scale and surge in the economic costs of SIM to society are large. Federal and state prevention and intervention programs should be financed with a clear understanding of the total costs-fiscal, social, and personal-incurred by deaths due to self-injurious behaviors
Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas
Use of fentanyl test strips by people who inject drugs
Declines in FTS use are consistent with what syringe services programs have been signaling for years. Needs assessments to gauge interest in FTS before scaling up can help ensure funding better spent on naloxone and syringes is not allocated to idle FTS. Increased FTS among women and racial minorities presents opportunities for tailored interventions. Recognizing trauma associated with witnessing overdoses as a growing component of the opioid epi…
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs
The War on Drugs, Racialized Capitalism, and Health Care Utilization Among White People Who Use Drugs in 22 Rural Appalachian Counties
Objectives. To analyze War on Drugs encounters and their relationships to health care utilization among White people who use drugs (PWUD) in 22 Appalachian rural counties in Kentucky, West Virginia, Ohio, and North Carolina. Methods. We recruited White PWUD using chain referral sampling in 2018 to 2020. Surveys asked about criminal–legal encounters, unmet health care needs, and other covariates. We used generalized estimating equations to regress…
Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs
BACKGROUND: Restrictive Medicaid policies regarding hepatitis C virus (HCV) treatment may exacerbate rural health care disparities for people who use drugs (PWUD). We assessed associations between Medicaid restrictions and HCV treatment among rural PWUD. METHODS: We compiled state-specific Medicaid treatment policies across 8 US rural sites in 10 states and merged these with participant survey data. We hypothesized that local restrictions regardi…
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities
HCV antibody positivity, indicating prior exposure, was highest among those who had recently injected opioids, alone or with stimulants. Additional nucleic acid testing is necessary to confirm active infection. More research is needed to determine the underlying causes of HCV antibody positivity by injection use
Prevalence and correlates of multiple injections per injection episode among people who inject drugs in rural U.S. communities
Barriers to accessing medications for opioid use disorder among rural individuals
Access barriers vary by MOUD type for rural individuals with OUD. Compared to sublingual buprenorphine, methadone access was hindered more by transportation difficulties, while injectable long-acting buprenorphine was hindered more by affordability and finding a doctor or program. These barriers highlight the need to de-regulate and expand locations for methadone access and prescribing, and to improve affordability and prescriber uptake of newer …
The Aids Drug Assistance Program Is a Model for Chronic Disease Treatment Support
Correlates of Rural Naloxone Possession Among People Who Use Drugs
Patterns of Felt Stigma Among Rural-Dwelling People Who Use Drugs
BACKGROUND: Stigma is a barrier to help-seeking in rural-dwelling people who use drugs. However, little is known about whether stigma is experienced in patterned ways, and what characteristics are associated with these patterns. METHODS: = 3048). We used three-step latent class analysis to classify participants by patterns of felt substance use stigma, then used multinomial logistic regression to explore demographic, health, and substance-related…
Use of fentanyl test strips by people who inject drugs
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on Covid-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C
Greater SDoH difficulties and lower self-efficacy were associated with greater inability to practice COVID-19 personal protective behaviors. Interventions to meet SDoH-related challenges and increase self-efficacy could help encourage practice of personal protective behaviors and economically reduce disease burden during health crises
Medicine (21 obras) · Opioid Use Disorder Treatment (14 obras) · Psychiatry (13 obras) · HIV, Drug Use, Sexual Risk (12 obras) · Environmental health (9 obras) · Internal Medicine (8 obras) · Psychology (8 obras) · Demography (7 obras) · Family medicine (6 obras) · Nursing (6 obras)